Pharmacovigilance system in Eurasian Economic Union
The article deals with the main provisions of the basic document - «Rules of good practice of pharmacovigilance of the Eurasian economic Union», which regulates the study and prevention of adverse reactions and other problems associated with drugs in the member States of the Union, including the Rus...
Αποθηκεύτηκε σε:
Κύριοι συγγραφείς: | I. L. Asetskaya (Συγγραφέας), S. K. Zyryanov (Συγγραφέας), A. S. Kolbin (Συγγραφέας), D. Yu. Belousov (Συγγραφέας) |
---|---|
Μορφή: | Βιβλίο |
Έκδοση: |
Izdatelstvo OKI,
2019-04-01T00:00:00Z.
|
Θέματα: | |
Διαθέσιμο Online: | Connect to this object online. |
Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|
Παρόμοια τεκμήρια
Παρόμοια τεκμήρια
-
Differences between the European and Eurasian Good Pharmacovigilance Practices
από: A. V. Matveev, κ.ά.
Έκδοση: (2021) -
Projecting cardiovascular deaths averted due to trans fat policies in the Eurasian Economic Union
από: Matthias Rieger, κ.ά.
Έκδοση: (2023) -
Review of calculation methods, procedures for registration and re-registration of producer prices of medicines in the countries of the Eurasian Economic Union
από: A. A. Leshkevich, κ.ά.
Έκδοση: (2020) -
Transition to the Non-Clinical Drug Development Principles and Rules of the Eurasian Economic Union: Changes, Challenges, and Prospects
από: A. A. Spasov
Έκδοση: (2023) -
That Eurasian
από: Bey, Aleph